| 000 | 01396 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250516211608.0 | ||
| 264 | 0 | _c20150213 | |
| 008 | 201502s 0 0 eng d | ||
| 022 | _a1098-660X | ||
| 024 | 7 |
_a10.1128/JCM.03533-13 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aScott, Lesley | |
| 245 | 0 | 0 |
_aMulticenter feasibility study to assess external quality assessment panels for Xpert MTB/RIF assay in South Africa. _h[electronic resource] |
| 260 |
_bJournal of clinical microbiology _cJul 2014 |
||
| 300 |
_a2493-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAntitubercular Agents _xpharmacology |
| 650 | 0 | 4 | _aFeasibility Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLaboratory Proficiency Testing _xmethods |
| 650 | 0 | 4 |
_aMolecular Diagnostic Techniques _xstandards |
| 650 | 0 | 4 | _aQuality Control |
| 650 | 0 | 4 |
_aRifampin _xpharmacology |
| 650 | 0 | 4 | _aSouth Africa |
| 650 | 0 | 4 |
_aTuberculosis, Multidrug-Resistant _xdrug therapy |
| 700 | 1 | _aAlbert, Heidi | |
| 700 | 1 | _aGilpin, Chris | |
| 700 | 1 | _aAlexander, Heather | |
| 700 | 1 | _aDeGruy, Kyle | |
| 700 | 1 | _aStevens, Wendy | |
| 773 | 0 |
_tJournal of clinical microbiology _gvol. 52 _gno. 7 _gp. 2493-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/JCM.03533-13 _zAvailable from publisher's website |
| 999 |
_c23788987 _d23788987 |
||